AbbVie 2014 Annual Report Download - page 170
Download and view the complete annual report
Please find page 170 of the 2014 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160 -
161 -
162 -
163 -
164 -
165 -
166 -
167 -
168 -
169 -
170 -
171 -
172 -
173 -
174 -
175 -
176 -
177 -
178 -
179 -
180 -
181
-
182
 |
 |
13NOV201221352027
The audit committee may delegate pre-approval authority to one or more of its members. The member to
whom such authority is delegated must report any pre-approval decisions to the audit committee at its next scheduled
meeting.
Audit Committee Report
................................................................................................................................................................................................................................................................................................................................................................................................
Management is responsible for the preparation and integrity of AbbVie’s consolidated financial statements. The
independent registered public accounting firm is responsible for performing an audit of the consolidated financial
statements and expressing an opinion on the conformity of those financial statements with accounting principles
generally accepted in the United States of America. The audit committee reviews these processes on behalf of the board
of directors. In this context, the audit committee has reviewed and discussed the audited financial statements contained
in the 2014 Annual Report on Form 10-K with AbbVie’s management and its independent registered public accounting
firm.
The audit committee has discussed with the independent registered public accounting firm the matters required
to be discussed pursuant to Auditing Standards Section AU 380 (Communication with Audit Committees), as amended, as
adopted by the Public Company Accounting Oversight Board.
The audit committee has received the written disclosures and the letter from the independent registered public
accounting firm required by the applicable requirements of the Public Company Accounting Oversight Board regarding the
independent registered public accounting firm’s communications with the audit committee concerning independence, and
has discussed with the independent registered public accounting firm the firm’s independence. The audit committee has
also considered whether the provision of non-audit services is compatible with maintaining the independence of the
independent registered public accounting firm.
Based on the review and discussions referred to above, the audit committee recommended to the board of
directors that the audited financial statements be included in AbbVie’s Annual Report on Form 10-K for the year ended
December 31, 2014 filed with the Securities and Exchange Commission.
Audit Committee
R. Austin, Chair, W. Burnside, E. Rapp, and F. Waddell
50 2015 Proxy Statement
AUDIT INFORMATION